Suchergebnisse - "Qin, Shukui"

PubPharm (310)

101

Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status : A Noninterventional Registry Study ( EVIDENCE)

enthalten in: The oncologist | 2021

von Qin, S. | Ji, J. | Xu, R. | +9

102

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

enthalten in: Liver cancer | 2020

von Zhou, J. | Sun, H. | Wang, Z. | +75

103

Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p) : a randomised, double-blind, placebo-controlled, phase 3 study

enthalten in: The Lancet. Oncology | 2020

von Xu, J. | Shen, L. | Bai, C. | +24

CommentIn: Nat Rev Endocrinol. 2021 Jan;17(1):9-10. - PMID 33128026

104

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep) : a randomised, double-blind, placebo-controlled, phase 3 study

enthalten in: The Lancet. Oncology | 2020

von Xu, J. | Shen, L. | Zhou, Z. | +27

CommentIn: Nat Rev Endocrinol. 2021 Jan;17(1):9-10. - PMID 33128026

105

Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer : Analysis of the Phase 3 FRESCO Trial

enthalten in: Advances in therapy | 2020

von Li, J. | Guo, W. | Bai, Y. | +30

106

Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial

enthalten in: Advances in therapy | 2020

von Li, J. | Guo, W. | Bai, Y. | +30

107

Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial

enthalten in: Advances in therapy | 2020

von Li, J. | Guo, W. | Bai, Y. | +30

108

Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial

enthalten in: Advances in therapy | 2020

von Li, J. | Guo, W. | Bai, Y. | +30

109

Regorafenib in Chinese patients with metastatic colorectal cancer : Subgroup analysis of the phase 3 CONCUR trial

enthalten in: Journal of gastroenterology and hepatology | 2020

von Xu, J. | Xu, R. | Qin, S. | +20

110

A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2020

von Lu, S. | Chen, G. | Sun, Y. | +45